Numerous anomalies in AD pathogenesis, such as increased Aβ deposition, oxidative stress, and disruptions in energy metabolism, have been shown to result from impaired insulin signaling in the central nervous system [11]. This evidence concerns the gene INS and Alzheimer disease.